About

Senzo has developed a revolutionary lateral flow test which delivers the same accuracy as laboratory- based PCR, with results available within 10 minutes at a fraction of the cost. This breakthrough technology is currently being applied to the world’s most prevalent diseases and infections where earlier and more prevalent diagnoses can make the biggest impact. Founded with the goal of developing PCR accurate point-of-care diagnostics for the world’s most deadly diseases, Senzo Health builds high sensitivity, low-cost, real-time testing technologies. Senzo is a point-of-care and self-testing diagnostics company. You may have seen news of Senzo in the summer of 2022 when they announced their at-home COVID-19 test as an as-reliable option to the traditional PCR test.